BURLINGAME, Calif., July 31 /PRNewswire/ -- Collaborative Drug
Discovery invites you to submit your poster presentation and register at
http://www.acteva.com/go/cdd to attend the 2nd Annual CDD Community Meeting
(a free, 1-day event) on October 7th. The CDD Community Meeting is the best
place for the CDD community and all scientists to get together, discuss
their research projects, and showcase their work to others in the
Early List of Confirmed Speakers:
-- David Sullivan, MD, Johns Hopkins
-- Fred Buckner MD, University of Washington
-- Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad
Institute of MIT & Harvard
-- Conor Caffrey, PhD, Sandler Center, UCSF
-- Jean Claude-Bradley, PhD Dept. of Chemistry, Drexel University
-- Sean Ekins, PhD, ex-Pfizer/Lilly Computational Chemist
-- Andrea Altieri, PhD, ASINEX
-- Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR)
-- Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD
-- J. Leighton Read, MD (Alloy Ventures) -- Financing Biomedical
Innovation from academia to the market: From FluMist(TM) to Priority
Review Vouchers and other stories
-- Russell "Rusty" Bromley, Chief Operating Officer, Myelin Repair
Timely panel topics:
-- Panel #1: What Foundations are looking for from Academic researchers?
-- Panel #2: What makes collaborations successful within and between
Who should attend?
-- Scientists working in drug discovery
-- Researchers who are involved in collaborations or generate complex drug
-- Students who want to learn more about the drug discovery industry
-- People who wish to network, establish new or strengthen existing
-- Current CDD community members to set the collaborative platform's
-- Anyone interested in new drugs for diseases of the developing world,
private public partnerships, and/or global health
So register now at http://www.acteva.com/go/cdd to join us on October 7th at the J. David Gladstone Research Institute (UCSF Mission Bay Campus, 1650 Owens Street, San Francisco, CA).
About Collaborative Drug Discovery, Inc.
Collaborative Drug Discovery, Inc. (CDD) -- http://www.collaborativedrug.com -- provides web-based software that organizes preclinical research data to help scientists advance new drug candidates more effectively. The CDD database enables scientists to "archive, mine, and collaborate"(R) around preclinical chemical and biological drug discovery data through a web-based interface. The software helps distributed research groups to safely store and intelligently analyze small molecule, enzyme, cell and animal bioactivity data accumulated from both low-throughput and high-throughput screens. Unique collaboration features and CDD's community-oriented approach help unite globally dispersed humanitarian efforts against neglected infectious diseases. Similar collaborative strategies are also rapidly gaining prominence in the commercial arena. CDD offers its industrial-strength database software at a price affordable to academic laboratories, research foundations, and small companies.
|SOURCE Collaborative Drug Discovery, Inc.|
Copyright©2008 PR Newswire.
All rights reserved